Loading financial data...

Anbio Biotechnology (NNNN) SEC Filings | Global Financial Data

Anbio Biotechnology

NNNNSEC EDGAR

In Vitro & In Vivo Diagnostic Substances(E9)CIK: 1982708

6-K

FORM 6-K

Filed: Feb 17, 2026 | Report: Feb 17, 2026

View on SEC

6-K

FORM 6-K

Filed: Jan 26, 2026 | Report: Jan 26, 2026

View on SEC

6-K

REPORT OF FOREIGN PRIVATE ISSUER

Filed: Dec 30, 2025 | Report: Dec 30, 2025

View on SEC

6-K

REPORT OF FOREIGN PRIVATE ISSUER

Filed: Nov 13, 2025 | Report: Nov 12, 2025

View on SEC

20-F

ANNUAL REPORT

Filed: Apr 28, 2025 | Report: Dec 31, 2024

View on SEC

6-K

REPORT OF FOREIGN PRIVATE ISSUER

Filed: Feb 21, 2025 | Report: Feb 21, 2025

FOR REGISTRATION OF CERTAIN CLASSES

Filed: Feb 14, 2025

View on SEC

F-1/A

REGISTRATION STATEMENT

Filed: Feb 10, 2025

View on SEC

F-1/A

REGISTRATION STATEMENT

Filed: Jan 24, 2025

View on SEC

FWP

FREE WRITING PROSPECTUS

Filed: Jan 22, 2025

View on SEC

F-1/A

REGISTRATION STATEMENT

Filed: Jan 10, 2025

View on SEC

F-1

REGISTRATION STATEMENT

Build with this data

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)

Get API Key (Free)